Quest Diagnostics unveiled a first-to-market blood test available for consumer purchase that helps assess the potential risk of developing Alzheimer’s disease. In adding AD-Detect, a single-blood-draw ...
Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...
GRAND RAPIDS, Mich. (WOOD) — PFAS has been making headlines for years now, and based on everything we know about PFAS contamination, it will be several more years before the chemical exposure is ...
LOS ANGELES (Reuters) - Quest Diagnostics Inc's molecular test for identifying patients infected with the H1N1 flu virus has been approved by European regulators and is available for distribution to ...
Narrow-moat Quest Diagnostics delivered second-quarter results that slightly exceeded our expectations on the top line, but that was offset by earnings that fell slightly short of our full-year ...
More than 6 million Americans are living with Alzheimer’s disease, the most common type of dementia, and that number is expected to reach 14 million by the year 2060. Doctors and researchers have long ...
In the June 2024 issue, we explore the ways that artificial intelligence is shaping our economy and culture. The stories and art are about AI—and occasionally by AI. (Throughout the issue, we have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback